Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$907M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$644M |
| 4 |
NVIDIA
NVDA
|
+$440M |
| 5 |
CRH
CRH
|
+$429M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
Home Depot
HD
|
+$377M |
| 3 |
Cigna
CI
|
+$322M |
| 4 |
Valero Energy
VLO
|
+$250M |
| 5 |
Amphenol
APH
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.35% |
| 2 | Technology | 9.23% |
| 3 | Healthcare | 7.6% |
| 4 | Financials | 5.15% |
| 5 | Consumer Discretionary | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3901
PUT
Pitney Bowes
PBI
$2.36B
| $1.29M | ﹤0.01% |
426,800
+416,600
| +4,084% | +$1.43M |
|
3902
Tanger
SKT
$4.33B
| $1.29M | ﹤0.01% |
56,932
-1,118,518
| -95% | -$26.1M |
|
3903
Pacific Biosciences
PACB
$435M
| $1.28M | ﹤0.01% |
153,717
-1,149,664
| -88% | -$13.1M |
|
3904
CALL
Tradeweb Markets
TW
$23B
| $1.28M | ﹤0.01% |
+16,000
| New | +$1.28M |
|
|
DISH
3905
CALL
DELISTED
DISH Network Corp.
DISH
| $1.28M | ﹤0.01% |
218,900
-261,500
| -54% | -$1.78M |
|
3906
iShares 10-20 Year Treasury Bond ETF
TLH
$11B
| $1.28M | ﹤0.01% |
+13,025
| New | +$1.37M |
|
3907
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
| $1.27M | ﹤0.01% |
15,736
-193,645
| -92% | -$15.7M |
|
3908
PUT
Lattice Semiconductor
LSCC
$16.2B
| $1.27M | ﹤0.01% |
+14,800
| New | +$1.34M |
|
3909
PUT
Jabil
JBL
$31.6B
| $1.27M | ﹤0.01% |
+10,000
| New | +$1.09M |
|
|
BELFB
3910
Bel Fuse Inc Class B
BELFB
$3.59B
| $1.27M | ﹤0.01% |
26,546
-33,493
| -56% | -$1.73M |
|
3911
CALL
Viking Therapeutics
VKTX
$3.75B
| $1.27M | ﹤0.01% |
114,400
-8,600
| -7% | -$123K |
|
3912
First Trust Capital Strength ETF
FTCS
$8B
| $1.26M | ﹤0.01% |
+17,174
| New | +$1.3M |
|
3913
iShares MSCI Saudi Arabia ETF
KSA
$648M
| $1.26M | ﹤0.01% |
+32,589
| New | +$1.33M |
|
3914
PUT
Duke Energy
DUK
$93.8B
| $1.26M | ﹤0.01% |
14,300
-4,000
| -22% | -$367K |
|
|
VCSA
3915
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $1.26M | ﹤0.01% |
136,626
+52,672
| +63% | +$640K |
|
|
GOEV
3916
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $1.26M | ﹤0.01% |
5,590
-3,196
| -36% | -$805K |
|
|
HI
3917
DELISTED
Hillenbrand
HI
| $1.26M | ﹤0.01% |
29,776
-38,179
| -56% | -$1.82M |
|
3918
Qfin Holdings
QFIN
$1.07B
| $1.26M | ﹤0.01% |
+81,816
| New | +$1.4M |
|
3919
CALL
ARK Genomic Revolution ETF
ARKG
$1.88B
| $1.25M | ﹤0.01% |
45,000
+10,000
| +29% | +$327K |
|
3920
German American Bancorp
GABC
$1.88B
| $1.25M | ﹤0.01% |
46,271
+36,140
| +357% | +$1.03M |
|
3921
Artivion
AORT
$1.31B
| $1.25M | ﹤0.01% |
82,485
-122,851
| -60% | -$1.99M |
|
3922
Assembly Biosciences
ASMB
$694M
| $1.25M | ﹤0.01% |
117,502
-3,066
| -3% | -$36.9K |
|
3923
HCI Group
HCI
$2.32B
| $1.25M | ﹤0.01% |
22,979
+9,197
| +67% | +$523K |
|
|
3924
Pitney Bowes
PBI
$2.36B
| $1.25M | ﹤0.01% |
412,867
+326,203
| +376% | +$1.12M |
|
|
PGRE
3925
DELISTED
Paramount Group
PGRE
| $1.25M | ﹤0.01% |
269,612
-240,462
| -47% | -$1.19M |
|
Similar funds
Israel Englander's Q3 2023 Portfolio in Review
As of Q3 2023, Israel Englander held 6,895 positions worth $198B, down 2.3% from $203B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Israel Englander deployed $6.14B of net new capital in Q3 2023, opening 836 new positions and adding to 2,326 existing holdings. Its largest new stake was Mobileye: 2,953,164 shares worth $123M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $689M trimmed.
- Israel Englander's largest Q3 2023 buy was Mobileye: 2,953,164 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.7B increase.
- Israel Englander's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $689M.
- Israel Englander fully exited Blackstone in Q3 2023, selling an estimated $178M.
- Israel Englander's ten largest holdings make up 21% of its $198B portfolio in Q3 2023.
- Israel Englander opened 836 new positions and closed 834 in Q3 2023.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $198B.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.